Effects of anti-CD2 monoclonal antibody: CD2- and CD95-mediated apoptosis of human peripheral T cells

Transplantation Proceedings

Volumn 31, Issue 1-2, 1999, Pages 1245-

  Mollereau, B ^a   Deas, O ^a   Dumont, C ^a   Charpentier, B ^a   Senik, A ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CYCLINE; DNA; FAS ANTIGEN; INTERLEUKIN 2; MONOCLONAL ANTIBODY CD 2; PROTEIN P27; UNCLASSIFIED DRUG;

APOPTOSIS; CELL CYCLE S PHASE; CONFERENCE PAPER; DNA SYNTHESIS; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD2; ANTIGENS, CD95; APOPTOSIS; CELLS, CULTURED; HUMANS; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 0345561676     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)01981-2     Document Type: Conference Paper

References (5)

1. Wyllie A.H., Kerr J.F.R., Currie A.R. Int Rev Cytol. 68:1980;251.
2. Russel J.H., White C.L., Loh D.Y., et al. Proc Natl Acad Sci USA. 88:1991;2151.
3. Rouleau M., Bernard A., Vernant J.P., et al. J Immunol. 151:1993;3547.
4. Rouleau M., Mollereau B., Bernard A., et al. J Immunol. 152:1994;4861.
5. Mollereau B., Deckert M., Deas O., et al. J Immunol. 56:1996;3184.